Viking Therapeutics Statistics
Total Valuation
VKTX has a market cap or net worth of $7.39 billion. The enterprise value is $6.48 billion.
| Market Cap | 7.39B |
| Enterprise Value | 6.48B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, after market close.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VKTX has 110.27 million shares outstanding. The number of shares has increased by 32.04% in one year.
| Shares Outstanding | 110.27M |
| Shares Change (YoY) | +32.04% |
| Shares Change (QoQ) | +3.51% |
| Owned by Insiders (%) | 6.00% |
| Owned by Institutions (%) | 74.71% |
| Float | 104.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.49, with a Debt / Equity ratio of 0.00.
| Current Ratio | 29.49 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.40% and return on invested capital (ROIC) is -12.23%.
| Return on Equity (ROE) | -18.40% |
| Return on Assets (ROA) | -17.70% |
| Return on Capital (ROIC) | -12.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.47M |
| Employee Count | 27 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +176.72% in the last 52 weeks. The beta is 1.12, so VKTX's price volatility has been higher than the market average.
| Beta (1Y) | 1.12 |
| 52-Week Price Change | +176.72% |
| 50-Day Moving Average | 71.98 |
| 200-Day Moving Average | 33.54 |
| Relative Strength Index (RSI) | 42.55 |
| Average Volume (30 Days) | 6,325,695 |
Short Selling Information
The latest short interest is 12.11 million, so 10.98% of the outstanding shares have been sold short.
| Short Interest | 12.11M |
| Short Previous Month | 11.15M |
| Short % of Shares Out | 10.98% |
| Short % of Float | 11.60% |
| Short Ratio (days to cover) | 4.46 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -114.36M |
| Pretax Income | -93.72M |
| Net Income | -93.72M |
| EBITDA | -93.43M |
| EBIT | -93.72M |
| Earnings Per Share (EPS) | -$0.93 |
Balance Sheet
The company has $963.01 million in cash and $1.18 million in debt, giving a net cash position of $961.83 million or $8.72 per share.
| Cash & Cash Equivalents | 963.01M |
| Total Debt | 1.18M |
| Net Cash | 961.83M |
| Net Cash Per Share | $8.72 |
| Equity / Book Value | 933.89M |
| Book Value Per Share | 8.47 |
| Working Capital | 933.56M |
Cash Flow
| Operating Cash Flow | -54.87M |
| Capital Expenditures | n/a |
| Free Cash Flow | -54.87M |
| FCF Per Share | -$0.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.04% |
| Shareholder Yield | -32.04% |
| Earnings Yield | -1.26% |
| FCF Yield | -0.74% |
Analyst Forecast
The average price target for VKTX is $103.44, which is 54.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $103.44 |
| Price Target Difference | 54.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |